文献速递关节外科

术前48至72小时进行SARS-CoV-2聚合酶链反应检测对初次及翻修髋膝关节置换术患者是安全的:一项国际多中心研究

Preoperative Severe Acute Respiratory Syndrome Coronavirus 2 Polymerase Chain Reaction Test at Between 48 and 72 Hours Preoperatively is Safe for Patients Undergoing Primary and Revision Hip and Knee Arthroplasty: A Multicentre International Study.
PubMed 文献 · J Arthroplasty · 2022-03-17

这项国际多中心观察性队列研究纳入1000例下肢关节置换术患者,其中935例(94%)在术前48至72小时完成SARS-CoV-2聚合酶链反应检测,并接受限制核酸检测与入院之间风险的建议及无COVID通道管理。30天内未发现SARS-CoV-2阳性病例,结论认为该策略对初次及翻修髋膝关节置换术患者是安全的,但单纯术前PCR检测可能安全尚需进一步充分把握度的研究。

要点

  • 1000例下肢关节置换术中935例(94%)在术前48至72小时完成SARS-CoV-2 PCR检测。
  • 所有病例经无COVID通道入院和手术,30天内未发现SARS-2阳性病例。
  • 术前48至72小时PCR检测联合无COVID通道对初次及翻修髋膝关节置换术患者是安全的。

核心结论

  • 术前48至72小时SARS-CoV-2 PCR检测,结合限制核酸检测与入院之间风险的建议及无COVID通道,对初次及翻修髋膝关节置换术患者是安全的。
  • 单纯术前SARS-CoV-2 PCR检测可能安全,但需要进一步充分把握度的研究。

研究设计与样本

  • 国际多中心观察性队列研究,纳入1000例下肢关节置换术病例。
  • 双主要结局为30天SARS-CoV-2阳性转化和30天SARS-CoV-2死亡率,次要结局包括30天SARS-CoV-2发病率。

主要发现

  • 1000例中935例(94%)在术前48至72小时完成PCR检测。
  • 初次膝关节置换占41%,初次髋关节置换占40%,翻修膝关节置换占11%,翻修髋关节置换占9%。
  • 6%的手术为急诊手术。
  • 30天内未发现SARS-CoV-2病例。

临床怎么用

  • 作者结论认为术前48至72小时SARS-CoV-2 PCR检测联合无COVID通道对初次及翻修髋膝关节置换术患者是安全的。
  • 作者指出该信息对当前大流行期间与患者共同决策很重要。

局限性

  • 原文结论指出单纯术前SARS-CoV-2 PCR检测可能安全,但需要进一步充分把握度的研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients undergoing lower limb arthroplasty who are severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive at the time of surgery have a high risk of mortality. The National Institute for Health and Clinical Care Excellence and the British Orthopaedic Association advise self-isolation for 14 days preoperatively in patients at a high risk of adverse outcomes due to COVID-19. The aim of the study is to assess whether preoperative polymerase chain reaction (PCR) for SARS-CoV-2 could be performed at between 48 and 72 hours preoperatively with specific advice about minimizing the risk of SARS-CoV-2 restricted to between PCR and admission. METHODS: A multicentre, international, observational cohort study of 1,000 lower limb arthroplasty cases was performed. The dual primary outcomes were 30-day conversion to SARS-CoV-2 positive and 30-day SARS-CoV-2 mortality. Secondary outcomes included 30-day SARS-CoV-2 morbidity. RESULTS: Of the 1,000 cases, 935 (94%) had a PCR between 48 and 72 hours preoperatively. All cases were admitted to and had surgery through a COVID-free pathway. Primary knee arthroplasty was performed in 41% of cases, primary hip arthroplasty in 40%, revision knee arthroplasty in 11%, and revision hip arthroplasty in 9%. Six percent of operations were emergency operations. No cases of SARS-CoV-2 were identified within the first 30 days. CONCLUSION: Preoperative SARS-CoV-2 PCR test between 48 and 72 hours preoperatively with advice about minimizing the risk of SARS-CoV-2 restricted to between PCR and admission in conjunction with a COVID-free pathway is safe for patients undergoing primary and revision hip and knee arthroplasty. Preoperative SARS-CoV-2 PCR test alone may be safe but further adequately powered studies are required. This information is important for shared decision making with patients during the current pandemic.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Hamilton TW, Ingelsrud LH, Gutman M, et al. Preoperative Severe Acute Respiratory Syndrome Coronavirus 2 Polymerase Chain Reaction Test at Between 48 and 72 Hours Preoperatively is Safe for Patients Undergoing Primary and Revision Hip and Knee Arthroplasty: A Multicentre International Study. J Arthroplasty. 2022. PMID: 35307532. doi:10.1016/j.arth.2022.03.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。